Literature DB >> 2407331

Alzheimer's disease--neuropathological aspects.

C Bergeron1.   

Abstract

Alzheimer's disease is characterized neuropathologically by the progressive atrophy and death of selected neuronal populations. Prominent cytoskeletal changes are also observed, as well as the formation of neuritic plaques associated with the abnormal deposition of amyloid in the brain. The nature, pathogenesis and distribution of these changes are discussed.

Entities:  

Mesh：

Year:  1990        PMID： 2407331      PMCID： PMC1255607     

Source DB:  PubMed          Journal:  Can J Vet Res        ISSN： 0830-9000            Impact factor:   1.310


  68 in total

Review 1.  Neuropeptidergic systems in plaques of Alzheimer's disease.

Authors:  R G Struble; R E Powers; M F Casanova; C A Kitt; E C Brown; D L Price
Journal:  J Neuropathol Exp Neurol       Date:  1987-09       Impact factor: 3.685

2.  Dendritic sprouting in Alzheimer's presenile dementia.

Authors:  A B Scheibel; U Tomiyasu
Journal:  Exp Neurol       Date:  1978-05-15       Impact factor: 5.330

3.  The fine structure of some intraganglionic alterations. Neurofibrillary tangles, granulovacuolar bodies and "rod-like" structures as seen in Guam amyotrophic lateral sclerosis and parkinsonism-dementia complex.

Authors:  A Hirano; H M Dembitzer; L T Kurland; H M Zimmerman
Journal:  J Neuropathol Exp Neurol       Date:  1968-04       Impact factor: 3.685

4.  Aminergic systems in Alzheimer's disease and Parkinson's disease.

Authors:  R J D'Amato; R M Zweig; P J Whitehouse; G L Wenk; H S Singer; R Mayeux; D L Price; S H Snyder
Journal:  Ann Neurol       Date:  1987-08       Impact factor: 10.422

5.  Failure of familial Alzheimer's disease to segregate with the A4-amyloid gene in several European families.

Authors:  C Van Broeckhoven; A M Genthe; A Vandenberghe; B Horsthemke; H Backhovens; P Raeymaekers; W Van Hul; A Wehnert; J Gheuens; P Cras
Journal:  Nature       Date:  1987 Sep 10-16       Impact factor: 49.962

6.  Alz 50, a monoclonal antibody to Alzheimer's disease antigen, cross-reacts with tau proteins from bovine and normal human brain.

Authors:  H Ksiezak-Reding; P Davies; S H Yen
Journal:  J Biol Chem       Date:  1988-06-15       Impact factor: 5.157

7.  The monoclonal antibody, Alz 50, recognizes tau proteins in Alzheimer's disease brain.

Authors:  N Nukina; K S Kosik; D J Selkoe
Journal:  Neurosci Lett       Date:  1988-05-03       Impact factor: 3.046

8.  The genetic defect in familial Alzheimer's disease is not tightly linked to the amyloid beta-protein gene.

Authors:  R E Tanzi; P H St George-Hyslop; J L Haines; R J Polinsky; L Nee; J F Foncin; R L Neve; A I McClatchey; P M Conneally; J F Gusella
Journal:  Nature       Date:  1987 Sep 10-16       Impact factor: 49.962

9.  Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques.

Authors:  R Katzman; R Terry; R DeTeresa; T Brown; P Davies; P Fuld; X Renbing; A Peck
Journal:  Ann Neurol       Date:  1988-02       Impact factor: 10.422

10.  Cortical somatostatin, neuropeptide Y, and NADPH diaphorase neurons: normal anatomy and alterations in Alzheimer's disease.

Authors:  N W Kowall; M F Beal
Journal:  Ann Neurol       Date:  1988-02       Impact factor: 10.422
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.